NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Clinical trials for NON-MUSCLE INVASIVE BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot targets bladder tumors in early trial
Disease control Recruiting nowThis early-stage study is testing a new drug, belzupacap sarotalocan, injected directly into bladder tumors to see if it's safe and feasible. About 55 adults with non-muscle-invasive bladder cancer will receive the injection, sometimes with a laser. The goal is to control the dis…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 01, 2026 14:37 UTC
-
New targeted therapy aims to keep bladder cancer from coming back
Disease control Recruiting nowThis study compares a new drug delivery system (TAR-210) to standard chemotherapy for people with a specific type of bladder cancer that hasn't invaded muscle. The treatment is placed directly into the bladder. About 641 participants will be randomly assigned to receive either TA…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 01, 2026 14:33 UTC
-
New targeted therapy aims to keep bladder cancer from returning
Disease control Recruiting nowThis study tests a new treatment called TAR-210 (erdafitinib) placed directly into the bladder, compared to standard chemotherapy, in people with high-risk bladder cancer that has a specific gene change (FGFR). Participants must have already received BCG treatment. The goal is to…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 01, 2026 14:31 UTC